Cargando…

Right ventricular wall motion abnormalities n Thalassemia Major patients

Detalles Bibliográficos
Autores principales:	Meloni, Antonella, Positano, Vincenzo, Armari, Sabrina, Secchi, Giuseppina, Izzi, Giancarlo, Salvatori, Cristina, Ascioti, Claudio, Restaino, Gennaro, Lombardi, Massimo, Pepe, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044268/ http://dx.doi.org/10.1186/1532-429X-16-S1-P257

Ejemplares similares

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

Different patterns of myocardial iron overload by T2* Cardiovascular MR as markers of risk for cardiac complication in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2012)

An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Different patterns of myocardial iron overload by multislice T2* Cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2011)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
por: Pepe, Alessia, et al.
Publicado: (2011)

Regional myocardial contractility in Thalassemia Major by magnetic resonance tagging
por: Meloni, Antonella, et al.
Publicado: (2014)

Changes of cardiac iron and function during pregnancy in trasfusion-dependent thalassemia patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

CMR T2* technique for segmental and global quantification of myocardial iron: multi-centre transfereability and healtcare impact evalaution
por: Positano, Vincenzo, et al.
Publicado: (2009)

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
por: Meloni, Antonella, et al.
Publicado: (2023)

T2* heterogeneity detected by CMR could be related to myocardial iron distribution in Thalassemia patients
por: Positano, Vincenzo, et al.
Publicado: (2009)

Significant improvement of survival by T2* CMR in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2016)

P1514: MULTI-PARAMETRIC CARDIAC MAGNETIC RESONANCE FOR RISK PREDICTION OF HEART FAILURE DEATH IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Prognostic CMR parameters for heart failure and arrhythmias in large cohort of well treated thalssemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Left ventricular global function index and left ventricular mass volume ratio by CMR: relation with heart failure in Thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2015)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Prospective changes of cardiac iron and function in low and intermediate-1 risk mds patients
por: Pepe, Alessia, et al.
Publicado: (2015)

Biventricular dimensions and function in pediatric sickle-cell disease and thalassemia major patients without cardiac iron
por: Meloni, Antonella, et al.
Publicado: (2013)

Left Ventricular Volumes, Mass and Function normalized to the body surface area, age and gender from CMR in a large cohort of well-treated Thalassemia Major patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
por: Meloni, Antonella, et al.
Publicado: (2023)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy
por: Spasiano, Anna, et al.
Publicado: (2021)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

Wellens’ syndrome with segmental wall-motion abnormalities
por: Celik, Turgay, et al.
Publicado: (2010)

Are the preferential patterns of myocardial iron overload preserved at the CMR follow-up?
por: Meloni, Antonella, et al.
Publicado: (2012)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2gboju8bjucffv8l97u7hbbmcr